398 related articles for article (PubMed ID: 35705809)
1. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
Hong C; Schubert M; Tijhuis AE; Requesens M; Roorda M; van den Brink A; Ruiz LA; Bakker PL; van der Sluis T; Pieters W; Chen M; Wardenaar R; van der Vegt B; Spierings DCJ; de Bruyn M; van Vugt MATM; Foijer F
Nature; 2022 Jul; 607(7918):366-373. PubMed ID: 35705809
[TBL] [Abstract][Full Text] [Related]
2. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
[TBL] [Abstract][Full Text] [Related]
3. IL6 Signaling Enables Survival of Chromosomally Instable Cancer Cells.
Cancer Discov; 2022 Aug; 12(8):1836. PubMed ID: 35748594
[TBL] [Abstract][Full Text] [Related]
4. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
[TBL] [Abstract][Full Text] [Related]
5. cGAS-STING signalling in cancer: striking a balance with chromosomal instability.
Beernaert B; Parkes EE
Biochem Soc Trans; 2023 Apr; 51(2):539-555. PubMed ID: 36876871
[TBL] [Abstract][Full Text] [Related]
6. The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability.
Hong C; Tijhuis AE; Foijer F
Cells; 2019 Oct; 8(10):. PubMed ID: 31658669
[TBL] [Abstract][Full Text] [Related]
7. cGAS-STING and the deadly CIN: how chronic inflammation represents a therapeutic vulnerability in chromosomally unstable cancers.
Bakhoum SF
Trends Cancer; 2022 Oct; 8(10):788-789. PubMed ID: 35915014
[TBL] [Abstract][Full Text] [Related]
8. Non-cell-autonomous cancer progression from chromosomal instability.
Li J; Hubisz MJ; Earlie EM; Duran MA; Hong C; Varela AA; Lettera E; Deyell M; Tavora B; Havel JJ; Phyu SM; Amin AD; Budre K; Kamiya E; Cavallo JA; Garris C; Powell S; Reis-Filho JS; Wen H; Bettigole S; Khan AJ; Izar B; Parkes EE; Laughney AM; Bakhoum SF
Nature; 2023 Aug; 620(7976):1080-1088. PubMed ID: 37612508
[TBL] [Abstract][Full Text] [Related]
9. DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling.
Wheeler OPG; Unterholzner L
Essays Biochem; 2023 Sep; 67(6):905-918. PubMed ID: 37534795
[TBL] [Abstract][Full Text] [Related]
10. Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
Yamada H; Takada M; Ghone D; Yu M; Nagashima T; Fujimoto H; Sakakibara J; Hasegawa Y; Takao S; Yamada A; Narui K; Ishikawa T; Suzuki A; Otsuka M
Sci Rep; 2024 Jun; 14(1):14146. PubMed ID: 38898119
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA drives noncanonical inflammation activation via cGAS-STING signaling pathway in retinal microvascular endothelial cells.
Guo Y; Gu R; Gan D; Hu F; Li G; Xu G
Cell Commun Signal; 2020 Oct; 18(1):172. PubMed ID: 33115500
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary.
Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A
Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal instability drives metastasis through a cytosolic DNA response.
Bakhoum SF; Ngo B; Laughney AM; Cavallo JA; Murphy CJ; Ly P; Shah P; Sriram RK; Watkins TBK; Taunk NK; Duran M; Pauli C; Shaw C; Chadalavada K; Rajasekhar VK; Genovese G; Venkatesan S; Birkbak NJ; McGranahan N; Lundquist M; LaPlant Q; Healey JH; Elemento O; Chung CH; Lee NY; Imielenski M; Nanjangud G; Pe'er D; Cleveland DW; Powell SN; Lammerding J; Swanton C; Cantley LC
Nature; 2018 Jan; 553(7689):467-472. PubMed ID: 29342134
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms and cellular functions of cGAS-STING signalling.
Hopfner KP; Hornung V
Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the cGAS-STING and NF-κB pathways-role in neurotoxicity.
Zhong S; Zhou Q; Yang J; Zhang Z; Zhang X; Liu J; Chang X; Wang H
Biomed Pharmacother; 2024 Jun; 175():116698. PubMed ID: 38713946
[TBL] [Abstract][Full Text] [Related]
17. Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer.
Sokač M; Ahrenfeldt J; Litchfield K; Watkins TBK; Knudsen M; Dyrskjøt L; Jakobsen MR; Birkbak NJ
Cancer Res Commun; 2022 Aug; 2(8):762-771. PubMed ID: 36923311
[TBL] [Abstract][Full Text] [Related]
18. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
19. TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling.
Epstein Shochet G; Brook E; Bardenstein-Wald B; Shitrit D
Respir Res; 2020 Feb; 21(1):56. PubMed ID: 32070329
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-autonomous cGAS-STING response confers drug resistance.
Lv QM; Lei HM; Wang SY; Zhang KR; Tang YB; Shen Y; Lu LM; Chen HZ; Zhu L
Cell Chem Biol; 2023 Jun; 30(6):591-605.e4. PubMed ID: 37263275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
